Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida
Overview
Paper Summary
This observational study of Florida adults found a correlation between receiving the Pfizer (BNT162b2) COVID-19 vaccine and a higher risk of 12-month all-cause mortality compared to receiving the Moderna (mRNA-1273) vaccine. However, the study's design cannot determine causality and residual confounding cannot be ruled out despite extensive matching.
Explain Like I'm Five
Scientists found that in Florida, adults who got the Pfizer COVID shot seemed to have a slightly higher chance of dying in the next year than those who got the Moderna shot. But they're not sure if the shot caused it, or if something else was at play.
Possible Conflicts of Interest
Joseph A. Ladapo, MD, PhD, is supported by the Florida Department of Health and serves as State Surgeon General. Retsef Levi, PhD has a financial relationship with Bluebell Foundation/Chicago Community Trust.
Identified Limitations
Rating Explanation
This observational study presents intriguing findings about higher all-cause mortality among BNT162b2 recipients compared to mRNA-1273 recipients. The extensive matching and large sample size are strengths, but the lack of detailed comorbidity data, potential for residual confounding, and inability to establish causality limit the strength of the conclusions. The authors acknowledge these limitations and the declared conflicts of interest are noted, placing this as an average study with suggestive but not definitive findings.
Good to know
This is the Starter analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.
Explore Pro →